Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM
Clinical trial NCT02112175 · COMPLETED
Trial details
- NCT number
- NCT02112175
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-30
- Primary completion
- 2020-10-12
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.